1 / 1

The Memo: Reach Neuro Creating the Next Frontier in Stroke Care

Reach Neurou2019s journey began with a shared vision: to restore independence and improve the quality of life for stroke survivors living with chronic motor deficits. Co-Founder Marco Capogrossou2019s pioneering work on spinal cord stimulation, which initially focused on lower limb recovery for spinal cord injury patients, laid the scientific groundwork for the company. For more details visit https://www.lifesciencemarketresearch.com/insights/the-memo-reach-neuro-creating-the-next-frontier-in-stroke-care

George125
Download Presentation

The Memo: Reach Neuro Creating the Next Frontier in Stroke Care

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Memo: Reach Neuro Creating the Next Frontier in Stroke Care Under the direction of Co-Founder and CEO Marc Powell, Reach Neuro is transforming the treatment landscape for chronic stroke patients with its groundbreaking spinal cord stimulation technology. This innovation—designed to restore volitional movement in individuals with long-term motor deficits—offers hope to millions of patients who have plateaued in traditional rehabilitation and face a lack of viable treatment options. Origin Story Reach Neuro’s journey began with a shared vision: to restore independence and improve the quality of life for stroke survivors living with chronic motor deficits. Co-Founder Marco Capogrosso’s pioneering work on spinal cord stimulation, which initially focused on lower limb recovery for spinal cord injury patients, laid the scientific groundwork for the company. “What makes stroke unique is that the damage is in the brain, not the spinal cord,” explained Powell. “The circuits we’re stimulating are intact, making stroke an ideal model for targeted spinal stimulation.” This insight led the team to explore how spinal cord stimulation could be adapted to upper-limb movement for stroke patients. The potential for significant quality-of-life improvements drove the team’s focus on upper-limb recovery. “Our patients talk about the daily challenges they face living with "one good arm,” and they have been thrilled to regain their independence,” Powell emphasized. This dual focus on scientific innovation and meaningful functional gains became the foundation for Reach Neuro. The team, including Capogrosso, Peter Gerszten, and Doug Weber, initiated clinical studies at the University of Pittsburgh and Carnegie Mellon University. Powell joined as a postdoctoral researcher to support these early trials, which delivered such promising results that the decision to commercialize the technology was clear. This blog is originally published here: https://www.lifesciencemarketresearch.com/insights/the-memo-reach-neuro- creating-the-next-frontier-in-stroke-care

More Related